Other grades of this product :
| Product Name: | M348 | | Synonyms: | N-[2-Chloro-5-(trifluoromethyl)phenyl]-4-(2-furanylcarbonyl)-1-piperazineacetamide;CS-2370;M348;ML348;ML-348 (ML348);GNF-Pf-1127;ML 348;GNF-PF-1127;1-Piperazineacetamide, N-[2-chloro-5-(trifluoromethyl)phenyl]-4-(2-furanylcarbonyl)- | | CAS: | 899713-86-1 | | MF: | C18H17ClF3N3O3 | | MW: | 415.79 | | EINECS: | 809-791-4 | | Product Categories: | | Mol File: | 899713-86-1.mol |
| Boiling point | 546.2±50.0 °C(Predicted) | | density | 1.422±0.06 g/cm3(Predicted) | | pka | 13.13±0.70(Predicted) |
| Uses | ML348 is a reversible LYPLA1 inhibitor. It is 14-fold selective for LYPLA1 over LYPLA2 and demonstrates little activity against a panel of more than 20 other serine hydrolases. | | Biochem/physiol Actions | ML348 is a substrate-competitive, reversible and APT1-selective acyl-protein thioesterase (APT) inhibitor (IC50/Ki = 840 nM/300 nM against APT1; IC50 & Ki >10 μM against APT2). ML348 effectively inhibits cellular APT1 activity in cultures (by >95% in HEK293T & mouse T cells; 5 μM for 4 h) and in mice in vivo (by >90% in lung/heart/kidney and by ~50% in brain tissue 4 h post 50 mg/kg i.p. dosing) without affecting more than 15 cellular serine hydrolases and APT2. |
| M348 Preparation Products And Raw materials |
|
日本语
한국어
Français
Deutsch
España
Türkiye